Machine Learning for Predicting Hyperglycemic Cases Induced by PD-1/PD-L1 Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Healthcare Engineering"
DOI: 10.1155/2022/6278854
Abstract: Objective Immune checkpoint inhibitors, such as programmed death-1/ligand-1 (PD-1/L1), exhibited autoimmune-like disorders, and hyperglycemia was on the top of grade 3 or higher immune-related adverse events. Machine learning is a model from past data for… read more here.
Keywords: predicting hyperglycemic; machine; machine learning; prediction ... See more keywords